Studies on complement systems in patients with primary biliary cirrhosis

Complement hemolytic activities (CH50, C3H50) and protein amounts of C3, C4 and split products C3d were studied in sera of patients with PBC, in which non-icteric patients were selected in order to avoid the influence of cholestasis on complement system. These complement values were considered from...

Full description

Saved in:
Bibliographic Details
Published inKanzo Vol. 31; no. 5; pp. 510 - 515
Main Authors KURODA, Masahito, MORITOH, Takao, TAKAGI, Tohru, KASUKAWA, Reiji, SAITOH, Koichi, OHBA, Takashi, NISHIMAKI, Tomoe
Format Journal Article
LanguageJapanese
Published The Japan Society of Hepatology 1990
Subjects
Online AccessGet full text
ISSN0451-4203
1881-3593
DOI10.2957/kanzo.31.510

Cover

Abstract Complement hemolytic activities (CH50, C3H50) and protein amounts of C3, C4 and split products C3d were studied in sera of patients with PBC, in which non-icteric patients were selected in order to avoid the influence of cholestasis on complement system. These complement values were considered from the points of complication of other autoimmune diseases in the patients and of granuloma in their liver. In the PBC patients without other autoimmune diseases, CH50 and C3d values were significantly higher than those of normal subjects (p<0.01), whereas C3 and C4 levels were normal. On the other hand, in the PBC patients complicated with other autoimmune diseases, CH50 levels were normal, whereas C4 levels were significantly lower than those of normal subjects (p<0.01). A positive correlation (p<0.05) between levels of C3 and C4 and also of CH50 and C3H50 were observed. In the PBC patients without other autoimmune diseases, mean levels of CH50, C3H50 and C3 of patients with granuloma in their liver were higher than those of patients without granuloma. These results would indicate that the complement system in PBC patients without other autoimmune diseases were activated through alternative pathway, whereas those in patients with PBC complicated with other autoimmune diseases were activated through classical pathway. Granuloma in the liver might be responsible for the abnormal activation of complement system.
AbstractList Complement hemolytic activities (CH50, C3H50) and protein amounts of C3, C4 and split products C3d were studied in sera of patients with PBC, in which non-icteric patients were selected in order to avoid the influence of cholestasis on complement system. These complement values were considered from the points of complication of other autoimmune diseases in the patients and of granuloma in their liver. In the PBC patients without other autoimmune diseases, CH50 and C3d values were significantly higher than those of normal subjects (p<0.01), whereas C3 and C4 levels were normal. On the other hand, in the PBC patients complicated with other autoimmune diseases, CH50 levels were normal, whereas C4 levels were significantly lower than those of normal subjects (p<0.01). A positive correlation (p<0.05) between levels of C3 and C4 and also of CH50 and C3H50 were observed. In the PBC patients without other autoimmune diseases, mean levels of CH50, C3H50 and C3 of patients with granuloma in their liver were higher than those of patients without granuloma. These results would indicate that the complement system in PBC patients without other autoimmune diseases were activated through alternative pathway, whereas those in patients with PBC complicated with other autoimmune diseases were activated through classical pathway. Granuloma in the liver might be responsible for the abnormal activation of complement system.
Author TAKAGI, Tohru
OHBA, Takashi
SAITOH, Koichi
NISHIMAKI, Tomoe
KASUKAWA, Reiji
KURODA, Masahito
MORITOH, Takao
Author_xml – sequence: 1
  fullname: KURODA, Masahito
  organization: The Second Department of Internal Medicine, Fukushima Medical College
– sequence: 1
  fullname: MORITOH, Takao
  organization: The Second Department of Internal Medicine, Fukushima Medical College
– sequence: 1
  fullname: TAKAGI, Tohru
  organization: The Second Department of Internal Medicine, Fukushima Medical College
– sequence: 1
  fullname: KASUKAWA, Reiji
  organization: The Second Department of Internal Medicine, Fukushima Medical College
– sequence: 1
  fullname: SAITOH, Koichi
  organization: The Second Department of Internal Medicine, Fukushima Medical College
– sequence: 1
  fullname: OHBA, Takashi
  organization: The Second Department of Internal Medicine, Fukushima Medical College
– sequence: 1
  fullname: NISHIMAKI, Tomoe
  organization: The Second Department of Internal Medicine, Fukushima Medical College
BookMark eNo9kM1OwzAQhC0EEqX0xgP4AUjx-iepj6gqFKkSB3q3bMehhsSpbCNUnp60qXrZkXa_WY3mDl2HPjiEHoDMqRTV07cOf_2cwVwAuUITWCygYEKyazQhXEDBKWG3aJaSN4TQsiJS0glaf-Sf2ruE-4Bt3-1b17mQcTqk7LqEfcB7nf2wSvjX5x3eR9_peMDGt_6o1se465NP9-im0W1ys7NO0fZltV2ui83769vyeVNYEGUomprWppbcSkcFsWCokwCVltJoQgmUNbe6toY3snRDRltqVpkKuNDcyAWbosfxrY19StE16pxIAVHHHtSpB8VADT0M-GrEv1LWn-4C65i9bd0IgyzJyTCOwXe5252OygX2D3i2bdA
ContentType Journal Article
Copyright The Japan Society of Hepatology
Copyright_xml – notice: The Japan Society of Hepatology
DBID AAYXX
CITATION
DOI 10.2957/kanzo.31.510
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1881-3593
EndPage 515
ExternalDocumentID 10_2957_kanzo_31_510
article_kanzo1960_31_5_31_5_510_article_char_en
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
CS3
JSF
KQ8
P2P
RJT
2WC
AAYXX
CITATION
OK1
ID FETCH-LOGICAL-c156n-fd2dbd94c9e250c1b2e9117a99ba02016d4cadcb4f96e709c6a37b7145a4b983
ISSN 0451-4203
IngestDate Tue Jul 01 02:48:11 EDT 2025
Wed Sep 03 06:30:02 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c156n-fd2dbd94c9e250c1b2e9117a99ba02016d4cadcb4f96e709c6a37b7145a4b983
OpenAccessLink https://www.jstage.jst.go.jp/article/kanzo1960/31/5/31_5_510/_article/-char/en
PageCount 6
ParticipantIDs crossref_primary_10_2957_kanzo_31_510
jstage_primary_article_kanzo1960_31_5_31_5_510_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1990
PublicationDateYYYYMMDD 1990-01-01
PublicationDate_xml – year: 1990
  text: 1990
PublicationDecade 1990
PublicationTitle Kanzo
PublicationTitleAlternate Kanzo
PublicationYear 1990
Publisher The Japan Society of Hepatology
Publisher_xml – name: The Japan Society of Hepatology
References 8) 森藤隆夫,大庭敬,大久保義光,他:SLE患者の血中補体成分解産物C3dに関する検討.臨免誌12: 8-14, 1989
16) Beswick DR, Klatskin G, Boyer JL: Asymptomatic prinary biliary cirrhosis: A progress report on long term follow-up and natural history. Gastroenterology 89: 267-271, 1985
6) Teisberg P, Gjone E: Circulating conversion products of C3 in liver disease. Clin Exp Immunol 14: 509-514, 1973
11) Lambre CR, Le Maho S, De Cremoux H, et al: Complement activity in pulmonary fluid during sarcoidosis. Ann NY Acad Sci 465: 233-241, 1986
12) Jaffe CJ, Vierling JM, Jones A, et al: Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. J Clin Invest 62: 1069-1077, 1978
2) Potter BJ, Elias E, Jones A: Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis. J Lab Clin Med 88: 427-439, 1975
9) 北村肇:各種疾患における補体の動態とその意義.3.肝疾患.「補体学」稲井,井上,田村編,医歯薬出版,東京, 1983, p302-313
5) Lindgren S, Laurell AB, Eriksson S: Complement components and activation in primary biliary cirrhosis. Hepatology 4: 9-14, 1984
15) Penner E, Reichlin M: Primary biliary cirrhosis associated with Sjögren's syndrome: Evidence for circulating and tissue-deposited Ro/Anti-immune complexes. Arthritis Rheum 25: 1250-1243, 1982
1) Potter BJ, Elias E, Thomas HC, et al: Complement metabolism in chronic liver disease: Catabolism of Clq in chronic active liver disease and primary biliary cirrhosis. Gastroenterology 78: 1034-1040, 1980
3) Wands JR, Dienstag JL, Bhan AK, et al: Circulating immune complexes and complement activation in primary biliary cirrhosis. New Eng J Med 298: 233-237, 1978
14) Ohshio G, Furukawa F, Manabe T, et al: Comparative studies on immunoglobulins, complement component (C3), albumin, and immunoglobulin A-containing circulating immune complexes in serum and bile of patients with biliary obstruction. Dig Dis Science 33: 570-576, 1988
4) Potter BJ, Elias E, Fayers PM, et al: Profieles of serum complement in patients with hepatobiliary diseases. Digestion 18: 371-383, 1978
7) Molles TE: Quantification of the C3d splits products of human complement by a sensitive enzyme-linked immunosorbent assay. Scand J Immunol 21: 607-613, 1985
10) Schutte M, DiCamelli R, Murphy P, et al: C3 proactivator (C3PA) as an acute phase reactant. Clin Exp Immunol 18: 251-256, 1974
17) Goldberg MJ, Kaplan MM, Mitamura T, et al: Evidence against an immune complex pathogenesis of primary biliary cirrhosis. Gastroenterology 83: 677-683, 1982
13) 新明紘一郎:実験的Endotoxinに対するUrsodeoxychol酸,Glycourosodeoxychol酸投与の影響.日消外会誌 18: 172-180, 1985
References_xml – reference: 1) Potter BJ, Elias E, Thomas HC, et al: Complement metabolism in chronic liver disease: Catabolism of Clq in chronic active liver disease and primary biliary cirrhosis. Gastroenterology 78: 1034-1040, 1980
– reference: 5) Lindgren S, Laurell AB, Eriksson S: Complement components and activation in primary biliary cirrhosis. Hepatology 4: 9-14, 1984
– reference: 10) Schutte M, DiCamelli R, Murphy P, et al: C3 proactivator (C3PA) as an acute phase reactant. Clin Exp Immunol 18: 251-256, 1974
– reference: 13) 新明紘一郎:実験的Endotoxinに対するUrsodeoxychol酸,Glycourosodeoxychol酸投与の影響.日消外会誌 18: 172-180, 1985
– reference: 7) Molles TE: Quantification of the C3d splits products of human complement by a sensitive enzyme-linked immunosorbent assay. Scand J Immunol 21: 607-613, 1985
– reference: 8) 森藤隆夫,大庭敬,大久保義光,他:SLE患者の血中補体成分解産物C3dに関する検討.臨免誌12: 8-14, 1989
– reference: 11) Lambre CR, Le Maho S, De Cremoux H, et al: Complement activity in pulmonary fluid during sarcoidosis. Ann NY Acad Sci 465: 233-241, 1986
– reference: 4) Potter BJ, Elias E, Fayers PM, et al: Profieles of serum complement in patients with hepatobiliary diseases. Digestion 18: 371-383, 1978
– reference: 12) Jaffe CJ, Vierling JM, Jones A, et al: Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. J Clin Invest 62: 1069-1077, 1978
– reference: 14) Ohshio G, Furukawa F, Manabe T, et al: Comparative studies on immunoglobulins, complement component (C3), albumin, and immunoglobulin A-containing circulating immune complexes in serum and bile of patients with biliary obstruction. Dig Dis Science 33: 570-576, 1988
– reference: 16) Beswick DR, Klatskin G, Boyer JL: Asymptomatic prinary biliary cirrhosis: A progress report on long term follow-up and natural history. Gastroenterology 89: 267-271, 1985
– reference: 15) Penner E, Reichlin M: Primary biliary cirrhosis associated with Sjögren's syndrome: Evidence for circulating and tissue-deposited Ro/Anti-immune complexes. Arthritis Rheum 25: 1250-1243, 1982
– reference: 6) Teisberg P, Gjone E: Circulating conversion products of C3 in liver disease. Clin Exp Immunol 14: 509-514, 1973
– reference: 3) Wands JR, Dienstag JL, Bhan AK, et al: Circulating immune complexes and complement activation in primary biliary cirrhosis. New Eng J Med 298: 233-237, 1978
– reference: 17) Goldberg MJ, Kaplan MM, Mitamura T, et al: Evidence against an immune complex pathogenesis of primary biliary cirrhosis. Gastroenterology 83: 677-683, 1982
– reference: 2) Potter BJ, Elias E, Jones A: Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis. J Lab Clin Med 88: 427-439, 1975
– reference: 9) 北村肇:各種疾患における補体の動態とその意義.3.肝疾患.「補体学」稲井,井上,田村編,医歯薬出版,東京, 1983, p302-313
SSID ssib002670992
ssib000940394
ssib002670224
ssib058493441
ssj0069113
ssib005879686
ssib002484534
Score 1.3501812
Snippet Complement hemolytic activities (CH50, C3H50) and protein amounts of C3, C4 and split products C3d were studied in sera of patients with PBC, in which...
SourceID crossref
jstage
SourceType Index Database
Publisher
StartPage 510
SubjectTerms C3d
complement
Granuloma
PBC
Title Studies on complement systems in patients with primary biliary cirrhosis
URI https://www.jstage.jst.go.jp/article/kanzo1960/31/5/31_5_510/_article/-char/en
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Kanzo, 1990/05/25, Vol.31(5), pp.510-515
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj5swELbSbVX1UvWpbl_yoT2Sgh-AL5VQX9lG26grVt0bMgYUshJUeVz2B-zv7viBQ6Q9dNsLCQYs7G8YfzOesRF6x6uGkDCWQdUIEjCmSCBFKINU0lilNRNJo10Dpz_i2Tn7fsEvJpPrUdTSbltO1dWNeSX_giqUAa46S_YWyPpKoQD-A75wBITh-FcYuyBA7fA3oeHG1ecWZ7bx4XbVVJfC9tutLKHjYfWvatfrZb9pN2OGOgey2Hs1fH62-JzZnJ6NXMLX7wFanJ3ki5mBW15KX55n8-zbiSnul-udrwjU9zz7lVlE21W79zZEwu7kOfWZajB-dz6cVE80wJC53bv_rdpiHKxSElq1VVu1mqZRQLndC3HQu077t-OZbaNEuQt0rd0Zv0nVE2H2J77UnTKl0dQ_dLB4toOmMLeBsgkLGhXcHuCJYriuU9xAou6guyRJIh0aOv85oqmChXRsBrOUcTo2YxNNhQ7OxWi2mqeJiPfL9AHnE9TQUMsYYhhwTCTE0HM2QUO38MO4fQfU6d4KrIch8tCQofwReuisGJzZdj1Gk5V8gu6fujiNp2jmJBP3Hd5LJnaSidsOD5KJtWRiJ5nYSSb2kvkM5V-_5J9mgduzI1ARj7ugqUhVVoIpUQO5VlFJamhdIoUoJVgmUVwxJStVskbENfSSiiVNyiRiXLJSpPQ5Our6rn6BMCEVGBvA78HiYGUC13lK6xgshqriqhHH6P3QG4V7ywIQ1b1m4TYoR-Ex-mi7yt91S6F4-b8VvEIP9KdkHXev0dF2vavfAJXdlm-NnP0BgXebrg
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Studies+on+complement+systems+in+patients+with+primary+biliary+cirrhosis&rft.jtitle=Kanzo&rft.au=KURODA%2C+Masahito&rft.au=MORITOH%2C+Takao&rft.au=TAKAGI%2C+Tohru&rft.au=KASUKAWA%2C+Reiji&rft.date=1990&rft.pub=The+Japan+Society+of+Hepatology&rft.issn=0451-4203&rft.eissn=1881-3593&rft.volume=31&rft.issue=5&rft.spage=510&rft.epage=515&rft_id=info:doi/10.2957%2Fkanzo.31.510&rft.externalDocID=article_kanzo1960_31_5_31_5_510_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0451-4203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0451-4203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0451-4203&client=summon